Carfecillin: antibacterial activity in vitro and in vivo.

Improved antibacterial activity and biocompatibility on vancomycin-loaded TiO2 nanotubes: in vivo and in vitro studies.

Antibacterial activity of resazurin-based compounds against Neisseria gonorrhoeae in vitro and in vivo.

Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.

Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity.

In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin.

Antibacterial activity of cinoxacin in vitro.

Probenecid and the antibacterial activity of cephradine in vivo.

Antibacterial activity of nitropyrroles, nitrothiphenes, and aminothiophenes in vitro.

Antibacterial activity of rosin and resin acids in vitro.

bioactive glass nanofibers: fabrication, antibacterial activity and inducing skin regeneration in vitro and in vivo.

Inhibited biofilm formation and improved antibacterial activity of a novel nanoemulsion against cariogenic Streptococcus mutans in vitro and in vivo.

In vivo and in vitro studies on soft denture materials: microbial adhesion and tests for antibacterial activity.

Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation.

Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro model.

In vivo antibacterial activity of MRX-I, a new oxazolidinone.

In vitro antibacterial activity of antiseptics against vaginal lactobacilli.

In vitro antibacterial activity of ME1207, a new oral cephalosporin.

In vitro antibacterial activity of different pulp capping materials.

In vitro antibacterial activity of poly (amidoamine)-G7 dendrimer.

In vitro antibacterial activity of Q-35, a new fluoroquinolone.

In vitro antibacterial activity of a new quinolone, NM394.

In vitro activity of cinoxacin, an organic acid antibacterial.

Antibacterial oxazolidinones. In vitro activity of a new analogue, E3709.

In-vitro activity of tosufloxacin, a new quinolone antibacterial agent.

Suggest Documents

Improved antibacterial activity and biocompatibility on vancomycin-loaded TiO2 nanotubes: in vivo and in vitro studies.

Antibacterial activity of resazurin-based compounds against Neisseria gonorrhoeae in vitro and in vivo.

Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.

Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity.

In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin.

Antibacterial activity of cinoxacin in vitro.

Probenecid and the antibacterial activity of cephradine in vivo.

Antibacterial activity of nitropyrroles, nitrothiphenes, and aminothiophenes in vitro.

Antibacterial activity of rosin and resin acids in vitro.

bioactive glass nanofibers: fabrication, antibacterial activity and inducing skin regeneration in vitro and in vivo.

Inhibited biofilm formation and improved antibacterial activity of a novel nanoemulsion against cariogenic Streptococcus mutans in vitro and in vivo.

In vivo and in vitro studies on soft denture materials: microbial adhesion and tests for antibacterial activity.

Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation.

Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro model.

In vivo antibacterial activity of MRX-I, a new oxazolidinone.

In vitro antibacterial activity of antiseptics against vaginal lactobacilli.

In vitro antibacterial activity of ME1207, a new oral cephalosporin.

In vitro antibacterial activity of different pulp capping materials.

In vitro antibacterial activity of poly (amidoamine)-G7 dendrimer.

In vitro antibacterial activity of Q-35, a new fluoroquinolone.

In vitro antibacterial activity of a new quinolone, NM394.

In vitro activity of cinoxacin, an organic acid antibacterial.

Antibacterial oxazolidinones. In vitro activity of a new analogue, E3709.

In-vitro activity of tosufloxacin, a new quinolone antibacterial agent.

Carfecillin: antibacterial activity in vitro and in vivo.

Recommend Documents

Follow Us